A 37-amino acid peptide derived from the calcitonin gene. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator.
As a potential drug, it has demonstrated in preclinical studies a profile that could make it an ideal anti-asthmatic drug candidate with bronchodilatory, bronchoprotecting and anti-inflammatory properties.
Investigated for use/treatment in myocardial infarction, heart disease, and asthma.
Duke University Health System, Durham, North Carolina, United States
Danish Headache Center, Copenhagen, Glostrup, Denmark
Danish Headache Center, Glostrup, Denmark
Mohammad Al-Mahdi Al-Karagholi, København S, Danmark, Denmark
Danish headache center, Glostrup, Copenhagen, Denmark
Danish Headache Center, Glostrup, Denmark
Rigshospitalet Glostrup, Glostrup, Denmark
Danish Headache Center, Rigshospitalet Glostrup, Copenhagen, Glostrup, Denmark
Danish Headache Center, University Hospital, Glostrup, Denmark
Danish Headache Center, University of Copenhagen, Faculty of Health Sciences, Department of Neurology, Glostrup Hospital, Glostrup, Copenhagen, Denmark
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.